Commvault Systems Inc vs 22nd Century Group Inc — how do they compare? Commvault Systems Inc trades at $157.25 (market cap $6.25B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Commvault Systems Inc is far larger — about 10053.6× 22nd Century Group Inc's market cap, and Commvault Systems Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Commvault Systems Inc for 17 Days and 22nd Century Group Inc for 32 Days on average.
| CVLT | XXII | |
|---|---|---|
Market Cap | $6.25B | $621.67K |
Volume | 632,727 | 45,625 |
Sector | Technology | Consumer Staples |
52-Week High | $176.43 | $483.00 |
52-Week Low | $75.18 | $0.80 |
Typical Hold Time | 17 Days | 32 Days |
Enterprise Value | $6.24B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Commvault Systems (CVLT) trades at $151.00, up 0.48% on the day, with a bullish technical signal and strong analyst support. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $1.42 surpassing the $1.16 estimate. The company maintains robust profitability metrics, including an 81.09% gross margin and 32.77% ROE, though valuation ratios like a P/E of 96.73 appear elevated. Positive news includes AWS competency achievements and new board appointments, reinforcing its market position.
The outlook remains favorable given earnings momentum and institutional confidence, but high valuation multiples pose a risk if growth moderates. Revenue is projected to rise to $1.2 billion in 2026, though net margin may compress. With no sell ratings and a consensus price target of $156.55, upside potential exists, but investors should monitor competitive pressures and execution on guidance.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →